Abstract:OBJECTIVE To evaluate the outcome of CO(2) laser treatment as primary therapy for vulvar condylomata acuminate and examine the risk factors and prediction model of single-period CO(2) laser treatment. METHODS Between March 2009 and December 2010, a multicenter prospective study was conducted at three 3A hospitals of China (Peking Union Medical College Hospital, Zhejiang Women's Health Hospital & Tongji Hospital). All enrolled patients of vulvar condylomata acuminata received CO(2) laser vaporization as the primary therapy and had return visits at 1, 3 and 6 months individually after treatment. Therapeutic recurrence and side effects were recorded. Logistic regression was used to analyze the associations between demographic or clinical characteristics and the outcome of single-period CO(2) laser treatment and a prediction model was established subsequently. The optimal cutoff value of model was evaluated by area under the receiver operating characteristic curve (AUC ROC). RESULTS A total of 160 patients completed a 6-month follow-up with a loss rate of 9.1% (16/176). And 131 patients (82%) were cured after the single-period CO(2) laser therapy with a total recovery rate of 94% (150/160). Side effects occurred in 50 (31%) patients with a complete self-recovery within 6 months. The most common side effects were local ulceration, pain and edema. No severe side effect was present. Large area of lesion (>8 cm(2)), vagina involved and unemployment were associated with the failure of single-period treatment while pain symptom was a protective factor of effectiveness. Age, marital status, symptom-free and vaginal involvement were not related with outcome. A prediction model was established as follows: Logit (P(0)) = -1.511+1.573X(1)+1.679X(2)+3.254X(3)-1.685X(4) (X(1)-X(4) representing area of lesion > 8 cm(2), vaginal involvement, unemployment and pain symptom respectively). The optimal cutoff value of P(0) was 0.35 with AUC ROC of 0.816 (P < 0.01). The sensitivity, specificity, positive predictive value and negative predictive value of model were 58.6%, 91.6%, 60.7% and 90.9% respectively. CONCLUSION CO(2) laser is effective and safe therapy for vulvar condylomata acuminata. A prediction model has been proposed to predict the outcome of single-period CO(2) laser therapy in initially diagnosed patients. It may guide clinical decision-making.

Therapeutic efficacy of condyloma acuminata by using 90Sr applicator and CO 2 laser: a meta-analysis

Detection of Foxp3+ CD4+ CD25+ Regulatory T Cells in the Peripheral Blood of Patients with Condyloma Acuminatum and Its Significance

Expression of Toll-like receptors in the lesions of condyloma acuminatum

Photodynamic therapy with aminolevulinic acid(ALA-PDT) for urethral condyloma acuminatum:a clinical observation

The Effect of the Crude Extracts from Condyloma Acuminata Lesions on the Expressions of IL-12 and IFN-γ

Expression of Activated Epidermal Growth Factor Receptor and Transcription Factor E2F in Condyloma Accuminata

Expression level and significance of Src-homology2 domain phosphatase-1 and -2 in condyloma acuminatum

[Detection of Peripheral Blood Th1/Th2 and Tc1/Tc2 Subsets in Patients with Condyloma Acuminatum and Its Significance].

[Outcome Prediction of Single-Period CO(2) Laser Therapy for Vulvar Condylomata Acuminate].

Effect of topical 5-aminolevulinic acid-mediated photodynamic therapy combined with CO 2 laser pretreatment for vaginal condyloma acuminate

A New Option for the Treatment of Condyloma Acuminatum in the Male Urethra: Multimodal Ultrasound Image-Guided Scraping and Photodynamic Therapy (USP)

Expression and Significance of Suppressor of Cytokine Signaling-1 and Protein Inhibitor of Activated STAT-1 in Condyloma Acuminatum

Evaluation of Photodynamic Therapy Using Topical Aminolevulinic Acid Hydrochloride in the Treatment of Condylomata Acuminata: a Comparative, Randomized Clinical Trial

The Study on Expression of Human Papillomavirus and Phosphotyrosione and Tyrosine Phosphatase 2 in Condyloma Acuminatum Tissue Remodeling

Observation of Topical Application with 5% Imiquimod Cream on Condyloma Acuminata Relapse Prevention

Comparison Between Photodynamic Therapy with Topical Application of 5-Aminolevulinic Acid and Co2 Laser Therapy in the Treatment of Cervical Condylomata Acuminate: A Randomized Controlled Trial

Efficacy of electrocauterization combined 5-aminolevulinic acid photodynamic therapy and interferon injection in the treatment of cervical condyloma acuminatum

Effect of the Integrated Traditional Medicine and Western Medicine on Condyloma Acuminatum

Combination of biopsy forceps excision and ALA-PDT for the treatment of cervical condylomata acuminata

Treatment of condyloma acuminata with carbon dioxide laser: a prospective study

Topical 5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of Condyloma Acuminatum: a Multicenter, Randomized, CO2 Laser-Controlled Trial